SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for FMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 876.20M
December 31, 2025 913.69M
September 30, 2025 824.40M
June 30, 2025 898.36M
March 31, 2025 790.07M
December 31, 2024 895.56M
September 30, 2024 830.66M
June 30, 2024 830.51M
March 31, 2024 841.85M
December 31, 2023 908.73M
September 30, 2023 863.51M
June 30, 2023 843.72M
March 31, 2023 839.21M
December 31, 2022 974.15M
September 30, 2022 996.26M
June 30, 2022 1.032B
March 31, 2022 977.39M
December 31, 2021 940.70M
September 30, 2021 861.92M
June 30, 2021 1.001B
March 31, 2021 857.01M
December 31, 2020 1.079B
September 30, 2020 838.91M
June 30, 2020 812.82M
March 31, 2020 941.34M
Date Value
December 31, 2019 902.32M
September 30, 2019 805.45M
June 30, 2019 901.76M
March 31, 2019 812.04M
December 31, 2018 831.84M
September 30, 2018 863.83M
June 30, 2018 851.69M
March 31, 2018 850.32M
December 31, 2017 1.123B
September 30, 2017 941.20M
June 30, 2017 990.74M
March 31, 2017 983.89M
December 31, 2016 768.00M
September 30, 2016 790.57M
June 30, 2016 744.94M
March 31, 2016 758.46M
December 31, 2015 775.00M
September 30, 2015 742.33M
June 30, 2015 722.62M
March 31, 2015 654.92M
December 31, 2014 673.92M
September 30, 2014 670.40M
June 30, 2014 638.38M
March 31, 2014 634.22M
December 31, 2013 635.24M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
DaVita, Inc. 421.91M
Rhön-Klinikum AG 52.33M
FamiCord AG 0.00
Acadia Healthcare Co., Inc. 53.20M
U.S. Physical Therapy, Inc. 18.27M